首页> 外文期刊>Pediatric clinics of North America >A practical guide to systemic lupus erythematosus.
【24h】

A practical guide to systemic lupus erythematosus.

机译:实用的系统性红斑狼疮指南。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Systemic lupus erythematosus is a challenging disease with varied manifestations resulting from widespread immune complex deposition. It may present in the general pediatric office as an acute illness with fever, rash, and hematuria, or as chronic fatigue and malaise that might be mistaken for "school phobia". Although SLE remains an infrequent disease in general pediatric practice, mild cases are more frequent than was previously recognized. These children benefit from therapy if the physician is alert to their occurrence and makes the appropriate diagnosis. The understanding of the role of genetics and environmental agents in the pathogenesis of SLE has improved over the past 10 years. In addition, the past 10 years have seen refinements in the use of immunosuppressive regimens, such as cyclophosphamide, that have led to both improved quality of life and improved survival for children with active SLE unresponsive to corticosteroids. Although long-term concerns regarding the safety and efficacy of immunosuppressive drug regimens persist, the future is increasingly bright for children with SLE who receive appropriate care in a timely fashion.
机译:系统性红斑狼疮是一种具有挑战性的疾病,由于广泛的免疫复合物沉积而导致各种表现形式。它可能在小儿科内以发烧,出疹子和血尿的急性疾病,或可能被误认为是“学校恐惧症”的慢性疲劳和不适而出现。尽管在一般儿科实践中,SLE仍然是一种罕见病,但轻度病例比以前认识到的更为常见。如果医生对他们的发生有所警觉并做出适当的诊断,则这些儿童将从治疗中受益。在过去的10年中,人们对遗传和环境因素在SLE发病机理中的作用的了解有所提高。此外,在过去的10年中,对免疫抑制方案(例如环磷酰胺)的使用有所改进,这不仅改善了生活质量,而且改善了对皮质类固醇无反应的活动性SLE儿童的生存率。尽管对免疫抑制药物疗法的安全性和有效性的长期关注仍然存在,但对于及时获得适当护理的SLE儿童而言,前途越来越光明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号